Kindling Investment Partners Announces Strategic Investment in MIMOSA Diagnostics
We are excited to announce that Kindling Investment Partners has made a strategic investment in MIMOSA Diagnostics, a pioneering company at the forefront of skin injury innovation.??
This partnership underscores our commitment to supporting groundbreaking advancements that have the potential to create new markets and change the world.
MIMOSA Diagnostics is revolutionizing the healthcare industry with its state-of-the-art, non-invasive skin assessment technology. Its proprietary platform enables real-time, point-of-care assessment of tissue health, providing unprecedented insights, and early detection capabilities. This technology is poised to transform how medical conditions are?assessed?and monitored, ultimately improving patient outcomes on a global scale.
Our investment in MIMOSA Diagnostics is a testament to the exceptional team behind the company. Led by visionary leaders and supported by a talented group of researchers and engineers, MIMOSA Diagnostics embodies the innovative spirit and dedication required to drive significant change in the healthcare landscape. Their collective expertise and passion for advancing medical technology align perfectly with Kindling Investment Partners' mission to fuel transformative ventures.
"We are thrilled to support MIMOSA Diagnostics in their journey to redefine the diagnostics market," said Josh Berg, Principal Partner at Kindling Investment Partners. "Their technology represents a quantum leap in medical skin injury assessments, offering a non-invasive, rapid, and accurate solution that will set a new standard in the industry. We believe in their vision and are confident that our partnership will accelerate their growth and impact."
领英推荐
"This investment from Kindling Investment Partners is a major milestone for MIMOSA Diagnostics," said Dr. Karen Cross, CEO & Co-Founder of MIMOSA Diagnostics. "Their strategic support and resources will be instrumental as we scale our operations and bring our revolutionary technology to a wider audience. Together, we are creating a new market that will change the way the world approaches healthcare diagnostics."
The collaboration between Kindling Investment Partners and MIMOSA Diagnostics exemplifies our shared dedication to fostering innovation and making a meaningful impact on global health. We are proud to partner with a company that is not only pushing the boundaries of medical technology but also creating solutions that will have a lasting, positive effect on the world.
About Kindling Investment Partners: Kindling Investment Partners is a leading Healthcare investment firm committed to supporting visionary companies that have the potential to create significant advancements in their respective fields. We are dedicated to fostering growth and helping transformative ventures achieve their full potential. https://bergcapitalmarkets.com/
About MIMOSA Diagnostics: MIMOSA Diagnostics Inc. is a leading provider of intuitive, equitable, and accessible healthcare technology. Their flagship solution, the MIMOSA Pro consists of a pocket-sized imaging device and a HIPAA-compliant web portal that streamlines tissue health assessments for clinicians by capturing temperature, tissue oxygenation, and digital images in less than one second. The images captured are automatically uploaded to the accompanying web portal where clinicians can monitor patient progress, identify early opportunities for intervention, and collaborate towards improved patient outcomes. To learn more about the MIMOSA Pro, visit?www.mimosadiagnostics.com
Operating Partner at Squeeze Massage | Consultant for AcuityMD
8 个月So happy to read this! Congratulations to you and Mimosa Team. Great company and amazing people.
Thank you Josh Berg and the entire Kindling team for supporting our mission of improving access to accurate and equitable skin injury assessments for every patient at the point-of-care.